Marijuana Stocks – MJ Shareholders https://mjshareholders.com The Ultimate Marijuana Business Directory Wed, 19 Mar 2025 17:29:13 +0000 en-US hourly 1 https://wordpress.org/?v=6.7.2 Charlotte’s Web Holdings, Inc. (CWBHF) Reports 2024 Fourth Quarter and Year-End Financial Results https://mjshareholders.com/charlottes-web-holdings-inc-cwbhf-reports-2024-fourth-quarter-and-year-end-financial-results/ Wed, 19 Mar 2025 17:29:13 +0000 https://marijuanastocks.com/?p=61248 Charlotte’s Web Reports 2024 Fourth Quarter and Year-End Financial Results Charlotte’s Web…

The post Charlotte’s Web Holdings, Inc. (CWBHF) Reports 2024 Fourth Quarter and Year-End Financial Results appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Charlotte’s Web Reports 2024 Fourth Quarter and Year-End Financial Results

Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), a market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year-ended December 31, 2024.

2024 Business Highlights

Achieved sequential quarterly revenue growth throughout 2024

Reduced operating expenses by over $22.4 million while strengthening operational performance

Successfully launched a new e-commerce platform with significantly enhanced capabilities

Expanded retail distribution, including 847 Walmart stores and now with a presence on Walmart.com, as well as Chewy.com, America’s largest online pet retailer

Introduced new product innovations, including functional mushroom gummies and CBD gel caps

Reduced operating expenses by over $22.4 million while strengthening operational performance

“2024 marked a turning point for Charlotte’s Web operationally as we delivered consecutive quarterly revenue growth, strengthened operations, and positioned the Company for sustained growth in 2025,” said Bill Morachnick, Chief Executive Officer of Charlotte’s Web. “With the successful launch of new product innovations, expanded retail partnerships, and transition underway to in-house manufacturing, we have laid the foundation for further strengthening the business in 2025. We’re particularly excited to announce that we will soon be offering our functional mushroom gummies on Amazon.com, representing our first meaningful presence on Amazon and introducing the Charlotte’s Web brand to millions of potential new customers. This not only diversifies our revenue streams but also reflects our commitment to access, including where consumers increasingly purchase health and wellness products. We are committed to delivering shareholder value through disciplined execution and continued expansion, evolving as a broader botanical wellness leader, beyond CBD.”

“Disciplined expense and cash flow management were top priorities throughout 2024,” added Erika Lind, Chief Financial Officer. “Our omnichannel strategy and operational optimization have been instrumental in navigating a complex regulatory environment while improving our cost structure. We executed significant expense reductions, reduced cash burn, and improved efficiencies across the business. The substantial improvement in our fourth quarter Adjusted EBITDA1 performance reflects the effectiveness of these measures, positioning us to continue reducing cash burn as we approach positive cash flow. We anticipate further improvements in 2025.”

2024 Business Review

Charlotte’s Web made significant strides in 2024, stabilizing its business and advancing strategic initiatives across product innovation, retail expansion, and operational efficiency.

Omnichannel Expansion and E-Commerce Growth
The Company’s new e-commerce platform, launched in mid-2024, improved site performance, enhanced the shopping experience and drove higher customer engagement. Advanced customer tools and marketing automation have increased conversion rates and sales volumes. New retail partnerships were added, including Walmart for topicals and Chewy.com for pet wellness products, further strengthening Charlotte’s Web’s national footprint. The transition toward an omnichannel model allows Charlotte’s Web to leverage direct-to-consumer (DTC), retail, and third-party platforms, streamlining distribution while broadening consumer accessibility.

New Product Innovations
New product innovations and categories included a successful expansion into minor cannabinoid CBN with the launch of Stay Asleep CBN Gummies, demonstrating strong demand for targeted botanical solutions and reinforcing Charlotte’s Web’s position in sleep wellness. In addition, launched in Q4 2024, Charlotte’s Web expanded into botanical wellness beyond CBD with functional mushroom gummies for focus, stress support, and energy.

Operational Efficiencies and Cost Management
Preparation for in-house manufacturing of gummies for full commercial production progressed in Q4 2024, with production ramp-up expected in 2025, improving margins and enhancing speed-to-market for future innovations. Expense reductions initiated in early 2024 materially lowered operating costs by $22.4 million, with similar spending continuing in 2025. The Company ended 2024 with $22.6 million in cash reserves, and the discipline of stringent expense management supports a strategic roadmap toward positive cash flow.

“With deeper retail penetration, new product categories, and improved operational efficiencies, we enter 2025 with momentum,” added Morachnick. “Charlotte’s Web is positioned to lead the next growth phase in botanical wellness while creating lasting value for shareholders.”

DeFloria Milestone
On February 24, 2025, the Company announced that the U.S. Food and Drug Administration (“FDA”) completed its review of the Phase 1 data and Investigational New Drug (“IND”) application submitted by DeFloria, Inc., an entity in which the Company is a stakeholder. The FDA has concluded that DeFloria may now proceed with the Phase 2 clinical trial for its botanical pharmaceutical candidate, AJA001 Oral Solution, a treatment for symptoms of autism spectrum disorder (“ASD”).

DeFloria is a collaboration between Charlotte’s Web, Ajna Biosciences, and British American Tobacco to develop AJA001 as a treatment for irritability associated with autism spectrum disorder. AJA001 employs the Company’s proprietary full-spectrum cannabidiol hemp extract derived from one of its patented cultivars. Charlotte’s Web has rights related to manufacturing for any eventual commercialization of AJA001 as an FDA-regulated botanical drug. Being the manufacturer of this product could represent a substantial long-term revenue opportunity for Charlotte’s Web upon potential FDA approval.

Financial Review

The following table sets forth selected financial information for the periods indicated:

Three months ended

Year ended

December 31,

December 31,

U.S. $ millions, except per share data

2024

2023

2024

2023

Revenue

$ 12.7

$ 15.9

$ 49.7

$ 63.2

Cost of goods sold

$ 7.6

$ 7.0

$ 28.4

$ 27.6

Gross profit

5.1

8.9

21.3

35.6

Selling, general and administrative expenses

10.6

18.6

53.3

75.6

Goodwill and asset impairments

0.6

0.6

Operating loss

(5.5)

(10.3)

(32.0)

(40.6)

Gain on initial investment in unconsolidated entity

10.7

Change in fair value of financial instruments and other

(0.1)

3.7

0.6

9.3

Other income (expense) , net

2.2

(1.4)

1.6

(2.7)

Income tax expense

(0.5)

(0.5)

Net loss

$ (3.4)

$ (8.5)

$ (29.8)

$ (23.8)

EPS basic and diluted

$ (0.02)

$ (0.06)

$ (0.19)

$ (0.16)

Adjusted EBITDA

$ 0.3

$ (6.5)

$ (12.6)

$ (22.7)

Assets:

Dec 31, 2024

Dec 31, 2023

Cash and cash equivalents

$ 22.6

$ 47.8

Total assets

$ 113.4

$ 152.5

Liabilities:

Long-term liabilities

$ 70.4

$ 73.3

Total liabilities

$ 86.4

$ 97.0

Fourth Quarter 2024 Financial Review

Consolidated net revenue for the fourth quarter ended December 31, 2024, was $12.7 million, compared to $15.9 million in the fourth quarter of 2023. Revenue increased modestly on a quarter-over-quarter basis versus Q3 2024 revenue of $12.6 million.

Quarterly revenue trend for 2024:

Q1

Q2

Q3

Q4

U.S. $ millions

2024

2024

2024

2024

Total revenue

$ 12.1

$ 12.3

$ 12.6

$ 12.7

In the fourth quarter, some retailers were negatively impacted by state regulations restricting the sale of certain CBD products, despite meeting federal requirements. However, e-commerce revenue increased quarter-over-quarter following the launch of the Company’s new e-commerce platform.

Gross Profit in Q4 2024 was $5.1 million, or 40.2% of revenue, compared to Gross Profit of $8.9 million, or 56.0% of revenue, in Q4 2023. The reduction in gross margin reflected holiday promotional investments, temporary shipping inefficiencies, and reduced fixed cost absorption on lower-than-expected revenue. The Company models gross margin to return above 50% in 2025.

Total selling, general, and administrative (“SG&A”) expenses in the quarter were $10.6 million, a 43% improvement from $18.6 million in Q4 2023. Stringent expense controls were implemented during the year to better align with current revenue levels.

Net loss for the fourth quarter of 2024 was $3.4 million, or ($0.02) per share basic and diluted, compared to a net loss of $8.5 million, or ($0.06) per share basic and diluted, for the fourth quarter of 2023.

Excluding depreciation, amortization and other non-cash items, Charlotte’s Web reported positive Adjusted EBITDA1 for the fourth quarter of 2024 of $0.3 million, a $6.8 million improvement compared to negative Adjusted EBITDA of $6.5 million in the fourth quarter of 2023.

Fiscal Year 2024 Financial Review
On a year-over-year basis, consolidated net revenue for the twelve months ended December 31, 2024, was $49.7 million, a decrease of 21.4% from $63.2 million in 2023. Revenue was negatively impacted by inflationary impacts on consumer spending and reduced retailer shelf allocations to the CBD category. The Company adopted a new e-commerce platform mid-year that has resulted in improving marketing, customer management, and sales volumes.

Gross profit for the year ended December 31, 2024, was $21.3 million, compared to $35.6 million for the year ended December 31, 2023. Gross profit was negatively impacted by a $4.1 million increase in inventory provision for 2024 due to the revaluation of aged hemp based on current market conditions. The increase was partially offset by lower inventory expenses and other variable costs associated with lower revenue in 2024. Gross profit before inventory provision was $25.4 million, or 51.1%, and $36.6 million, or 58.0%, in 2024 and 2023, respectively.

Total SG&A expense for 2024 was $53.3 million, compared to $75.6 million in the prior year. The $22.4 million or 29.6% decrease resulted from multiple actions taken in 2024 to reduce operating expenses and better align SG&A against the lower revenue levels, including workforce and insurance program adjustments, contract reviews and negotiations, and software optimizations. Additionally, in 2024, the Company amended its MLB Promotional Rights Agreement, resulting in a decrease in amortization and media expense related to MLB assets of approximately $4.9 million compared to 2023.

An operating loss of $32 million in 2024 improved 21.2% from an operating loss of $40.6 million in 2023. Net loss for 2024 was $29.8 million, or $(0.19) per share, basic and diluted, compared to a net loss of $23.8 million, or $(0.16) per share, basic and diluted, in 2023. The lower net loss in 2023 was due to a combined net gain of $20.0 million in that year in the fair value of the Company’s debt derivative and from its investment in DeFloria.

Excluding depreciation, amortization, and interest, the EBITDA1 loss for 2024 was $17.6 million, as compared to an EBITDA loss of $6.3 million for 2023. 2024 included a higher inventory provision than 2023, which included the combined net gain of $20.0 million in fair value of the Company’s debt derivative and from its investment in DeFloria. Excluding these items, the Adjusted EBITDA1 loss was $12.6 million for 2024, as compared to the Adjusted EBITDA loss of $22.7 million for 2023.

Balance Sheet and Cash Flow
Net cash used for operations in the fourth quarter of 2024 was $1.8 million. Net cash used for operations in the year ended December 31, 2024, was $21.2 million, including cash paid to MLB for license and media rights assets of $5 million. Capital expenditures of $3.9 million were primarily used for the in-house production of topical and gummy projects.

The Company’s cash and working capital as of December 31, 2024, were $22.6 million and $31.1 million, respectively, compared to $47.8 million and $54.5 million as of December 31, 2023, respectively.

“With reduced cash burn, having cash reserves exceeding $22 million provides the runway for 2025 growth and beyond,” said Mrs. Lind. “In-house production will increase in 2025, and continued expense discipline is key to stabilizing our financial position.”

Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s audited consolidated financial statements and accompanying notes for the three and twelve-month periods ended December 31, 2024, and 2023, and related management’s discussion and analysis of financial condition and results of operations (“MD&A”), are reported in the Company’s 10-K filing on the Securities and Exchange Commission website at www.sec.gov and on SEDAR+ at www.sedarplus.ca and will be available on the Investor Relations section of the Company’s website at https://investors.charlottesweb.com.

Analyst Conference Call
Management will host a conference call to discuss the Company’s 2024 fourth quarter and year-end results at 11:00 A.M. ET on March 19, 2025.

There are three ways to join the call:

Register and enter your phone number at https://emportal.ink/3EK35Bz to receive an instant automated call back, or

Dial 1-646-357-8785 or 1-800-836-8184 approximately 10 minutes before the conference call, or

Listen to the live webcast online.

Earnings Call Replay
A recording of the call will be available through March 26, 2025. To listen to a replay of the earnings call, please dial 1- 646-517-4150 or 1-888-660-6345 and provide conference replay ID 90317#. A webcast of the call will also be accessible through the investor relations section of the Company’s website for an extended period of time.

Subscribe to Charlotte’s Web investor news.

About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is the market leader in innovative hemp extract wellness products that include Charlotte’s Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD certified NSF for Sport®. Charlotte’s Web branded premium quality full-spectrum CBD extract products start with proprietary hemp genetics that are North American farm-grown using organic and regenerative cultivation practices. The Company’s hemp extracts have naturally occurring botanical compounds including cannabidiol (“CBD”), CBN, CBC, CBG, terpenes, flavonoids, and other beneficial compounds. Charlotte’s Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte’s Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte’s Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and online through the Company’s website at www.charlottesweb.com.

Shares of Charlotte’s Web trade on the Toronto Stock Exchange (TSX) under the symbol “CWEB” and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol “CWBHF”.

Charlotte’s Web is the official CBD of Major League Baseball©.

© Major League Baseball trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com.

(1)

Non-GAAP Measures: The press release contains non-GAAP measures, including EBITDA and Adjusted EBITDA. Please refer to the section in the tables captioned “Non-GAAP Measures” below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.

Forward-Looking Information
Certain information provided herein constitutes forward-looking statements or information (collectively, “forward-looking statements”) within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as “may”, “will”, “should”, “could”, “anticipate”, “expect”, “project”, “estimate”, “forecast”, “plan”, “intend”, “target”, “believe” and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company in light of its experience and perception of historical trends, current conditions and expected future development and other factors that it believes are appropriate and reasonable.

Specifically, this press release contains forward-looking statements relating to, but not limited to: organizational changes, marketing plans and operational platform upgrades, and the impact of these initiatives on retail expansion, operational efficiencies, cash flow,‎ revenue and e-commerce monetization; expectations relating to IT upgrades, marketing optimization and operational integrations; product expansion activities and the corresponding ‎results thereof; sales volume ad gross margin expectations; anticipated timing for, and business impact of, in-house manufacturing of topical ‎and gummy products; ‎the impact of the Company’s product innovations on product development; regulatory developments and the impact of developments on both consumer action and the Company’s opportunities and operations; activities relating to, and sponsorship of, legislation to advance regulatory framework; the impact of insourcing on operating margins, capital expenditures and R&D; anticipated consumer trends and corresponding product innovation; anticipated future financial results; the impact of the Company’s partnership with the MLB and PLL on the Company’s exposure and sales; the Company’s ability to increase online traffic and demographic exposure through new products and marketing; and the impact of certain activities on the Company’s business and financial condition and anticipated trajectory.

The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to: regulatory regime changes; anticipated product development and sales; the success of sales and marketing activities; product development and production expectations; outcomes from R&D activities; the Company’s ability to deal with adverse growing conditions in a timely and cost-effective manner; the availability of qualified and cost-effective human resources; compliance with contractual and regulatory obligations and requirements; availability of adequate liquidity and capital to support operations and business plans; and expectations around consumer product demand. In addition, the forward-looking statements are subject to risks and uncertainties pertaining to, among other things: supply and distribution chains; the market for the Company’s products; revenue fluctuations; regulatory changes; loss of customers and retail partners; retention and availability of talent; competing products; share price volatility; loss of proprietary information; product acceptance; internet and system infrastructure functionality; information technology security; available capital to fund operations and business plans; crop risk; economic and political considerations; and including but not limited to those risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, and other risk factors contained in other filings with the Securities and Exchange Commission available on www.sec.gov and filings with Canadian securities regulatory authorities available on www.sedarplus.ca. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty as these are interdependent, and the Company’s future course of action depends on management’s assessment of all information available at the relevant time.

Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company’s behalf, are expressly qualified in their entirety by these cautionary statements.

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands of U.S. dollars, except share and per share amounts)

December 31,

2024

2023

ASSETS

Current assets:

Cash and cash equivalents

$ 22,618

$ 47,820

Accounts receivable, net

1,263

1,950

Inventories, net

18,907

21,538

Prepaid expenses and other current assets

4,194

6,864

Total current assets

46,982

78,172

Property and equipment, net

26,337

27,513

License and media rights

13,691

17,070

Operating lease right-of-use assets, net

12,876

14,601

Investment in unconsolidated entity

10,800

11,000

SBH purchase option and other derivative assets

1,075

2,602

Intangible assets, net

1,049

887

Other long-term assets

632

703

Total assets

$ 113,442

$ 152,548

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$ 3,426

$ 2,860

Accrued and other current liabilities

5,246

8,682

Lease obligations – current

2,055

2,252

License and media rights payable – current

5,209

9,852

Total current liabilities

15,936

23,646

Convertible debenture

43,631

42,528

Lease obligations

13,652

15,655

License and media rights payable

11,809

11,338

Derivative and other long-term liabilities

1,327

3,823

Total liabilities

86,355

96,990

Commitments and contingencies

Shareholders’ equity:

Common shares, nil par value; unlimited shares authorized; 158,009,541 and 154,332,366 shares issued and outstanding as of December 31, 2024 and 2023, respectively

1

1

Additional paid-in capital

328,655

327,280

Accumulated deficit

(301,569)

(271,723)

Total shareholders’ equity

27,087

55,558

Total liabilities and shareholders’ equity

$ 113,442

$ 152,548

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands of U.S. dollars, except share and per share amounts)

Year Ended December 31,

2024

2023

Revenue

$ 49,667

$ 63,155

Cost of goods sold

28,407

27,589

Gross profit

21,260

35,566

Selling, general and administrative expenses

53,247

75,630

Asset impairment

548

Operating loss

(31,987)

(40,612)

Gain on initial investment in unconsolidated entity

10,700

Change in fair value of financial instruments

615

9,339

Other income (expense), net

1,565

(2,694)

Loss before provision for income taxes

$ (29,807)

$ (23,267)

Income tax expense

(39)

(529)

Net loss

$ (29,846)

$ (23,796)

Per common share amounts

Net loss per common share, basic and diluted

$ (0.19)

$ (0.16)

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands of U.S. dollars, except share amounts)

Common Shares

Additional
Paid-in
Capital

Accumulated
Deficit

Total
Shareholders’
Equity

Shares

Amount

Balance—December 31, 2022

152,135,026

$ 1

$ 325,431

$ (247,927)

$ 77,505

Common shares issued upon vesting of restricted share units, net of withholdings

2,197,340

(251)

(251)

Share-based compensation

2,100

2,100

Net loss

(23,796)

(23,796)

Balance—December 31, 2023

154,332,366

$ 1

$ 327,280

$ (271,723)

$ 55,558

Common shares issued upon vesting of restricted share units, net of withholding

3,677,175

(145)

(145)

Share-based compensation

1,520

1,520

Net loss

(29,846)

(29,846)

Balance—December 31, 2024

158,009,541

$ 1

$ 328,655

$ (301,569)

$ 27,087

CHARLOTTE’S WEB HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of U.S. dollars)

Year Ended December 31,

2024

2023

Cash flows from operating activities:

Net loss

$ (29,846)

$ (23,796)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

9,979

15,160

Change in fair value of financial instruments

(615)

(9,339)

Gain on initial investment in unconsolidated entity

(10,700)

Convertible debenture and other accrued interest

3,724

3,857

Gain on foreign currency transaction

(3,631)

1,142

Share-based compensation

1,520

2,100

Changes in right-of-use assets

1,771

1,918

Allowance for credit losses

140

1,240

Inventory provision

4,154

1,039

Asset impairment

548

Other

611

3,313

Changes in operating assets and liabilities:

Accounts receivable, net

361

(809)

Inventories, net

(1,520)

4,376

Prepaid expenses and other current assets

1,332

85

Operating lease obligations

(2,247)

(2,304)

Accounts payable, accrued and other liabilities

(1,664)

151

License and media rights payable

(5,000)

(8,000)

Income tax and other receivable

4,261

Other operating assets and liabilities, net

(330)

372

Net cash used in operating activities

(21,261)

(15,386)

Cash flows from investing activities:

Purchases of property and equipment and intangible assets

(3,851)

(3,691)

Proceeds from sale of assets

55

185

Net cash provided by/(used in) investing activities

(3,796)

(3,506)

Cash flows from financing activities:

Other financing activities

(145)

(251)

Net cash used in financing activities

(145)

(251)

Net decrease in cash and cash equivalents

(25,202)

(19,143)

Cash and cash equivalents —beginning of year

47,820

66,963

Cash and cash equivalents —end of year

$ 22,618

$ 47,820

Non-cash activities:

Non-cash issuance of note receivable

(170)

Non-cash purchases of property and equipment and intangibles

(3)

(233)

(1) Non-GAAP Measures – EBITDA and Adjusted EBITDA
Earnings before interest, taxes, depreciation, and amortization (“EBITDA”) is not a recognized performance measure under U.S. GAAP. The term EBITDA consists of net loss and excludes interest, taxes, depreciation, and amortization. Adjusted EBITDA also excludes other non-cash items such as changes in fair value of financial instruments (Mark-to-Market), Share-based compensation, and impairment of assets. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. The non-GAAP financials measures do not have a standardized meaning prescribed under U.S. GAAP and therefore may not be comparable to similar measures presented by other issuers. The primary purpose of using non-GAAP financial measures is to provide supplemental information that we believe may be useful to investors and to enable investors to evaluate our results in the same way we do. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, we use these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware, however, that not all companies define these non-GAAP measures consistently.

(1)

EBITDA and Adjusted EBITDA are non-GAAP financial measures with reconciliations provided in the table below:

Adjusted EBITDA for the three and twelve months ended December 31, 2024, and 2023 is as follows:

Charlotte’s Web Holdings, Inc.

Statement of Adjusted EBITDA

(In Thousands)

Three Months Ended

Year Ended

December 31,

December 31,

(unaudited)

(audited)

U.S. $ Thousands

2024

2023

2024

2023

Net loss

$ (3,371)

$ (8,589)

$ (29,846)

$ (23,796)

Depreciation of property and equipment and amortization of intangibles

2,473

3,650

9,979

15,160

Interest (income) expense

643

350

2,201

1,786

Income tax expense

(22)

529

39

529

EBITDA

(277)

(4,060)

(17,627)

(6,321)

Stock Comp

223

454

1,520

2,100

Mark-to-market financial instruments

86

(3,752)

(615)

(9,339)

Impairment

548

548

Inventory Provision

228

309

4,154

1,039

Initial gain on investment in DeFloria

(10,700)

Adjusted EBITDA

$ 260

$ (6,501)

$ (12,568)

$ (22,673)

View original content to download multimedia:https://www.prnewswire.com/news-releases/charlottes-web-reports-2024-fourth-quarter-and-year-end-financial-results-302405400.html

SOURCE Charlotte’s Web Holdings, Inc.

The post Charlotte’s Web Holdings, Inc. (CWBHF) Reports 2024 Fourth Quarter and Year-End Financial Results appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
March 2025’s Top Cannabis Stocks: Key Players in the Growing Market https://mjshareholders.com/march-2025s-top-cannabis-stocks-key-players-in-the-growing-market/ Tue, 18 Mar 2025 21:28:32 +0000 https://marijuanastocks.com/?p=61242 Top US Pot Stocks To Watch Now

The post March 2025’s Top Cannabis Stocks: Key Players in the Growing Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Best Marijuana Stocks to Watch in March 2025 as Legalization Efforts Continue

The U.S. cannabis industry continues to expand, creating opportunities for investors. In 2024, legal cannabis sales surpassed $30 billion, and analysts expect growth to reach $40 billion by 2025. Several states are pushing for new legalization measures, which could drive more revenue into the sector. Recently, lawmakers have discussed potential federal cannabis reform, including banking access and decriminalization efforts. This news has sparked renewed interest in marijuana penny stocks, which often see high volatility. These low-priced stocks can deliver significant gains but also have higher risks.

Investors should use technical analysis to identify potential entry points before making decisions. Support and resistance levels, moving averages, and trading volume can help confirm price trends. Proper risk management is also essential when trading volatile stocks. Setting stop-loss orders and managing position sizes can help limit losses. As market conditions shift, these penny stocks may offer opportunities for short-term gains in the cannabis sector.

The cannabis industry continues to show resilience despite recent market fluctuations. Many investors are watching for potential growth as legalization efforts progress. The U.S. cannabis market is projected to reach $40 billion by 2025, making it an attractive sector. Companies with strong market positions and expanding operations could see significant gains in the coming months.

This article highlights three top marijuana stocks to watch in March 2025. These companies have notable footprints in the U.S. cannabis industry. They also have strong financials that suggest growth potential. Here’s a closer look at Planet 13 Holdings Inc. (PLNHF), Glass House Brands Inc. (GLASF), and Cresco Labs Inc. (CRLBF).

[Read More] 3 Top Marijuana For Better Trading After Earnings

Top 3 Marijuana Stocks to Watch in March 2025

  1. Planet 13 Holdings Inc. (OTC: PLNHF)
  2. Glass House Brands Inc. (OTC: GLASF)
  3. Cresco Labs Inc. (OTC: CRLBF)

Planet 13 Holdings Inc. (PLNHF)

Planet 13 Holdings Inc. is a well-known cannabis company focusing on superstore dispensaries. It operates some of the largest cannabis retail locations in the U.S. The company is best known for its Las Vegas Superstore, a massive dispensary with an immersive shopping experience.

Besides its flagship location, Planet 13 has expanded to California and Florida. In California, it operates a large dispensary in Santa Ana. The company is also developing additional stores in other high-traffic locations. With plans to expand further, Planet 13 aims to be a leader in the premium cannabis retail market.

Latest Financial Performance

Planet 13 reported strong revenue growth in its latest earnings report. In the most recent quarter, revenue reached $28.5 million, marking an increase from the previous year. This growth was driven by higher foot traffic and increased product offerings.

The company’s gross profit margin improved as well, reaching 50%. This was due to better cost management and strong sales of in-house brands. However, operating expenses remained high due to expansion efforts. Planet 13 continues investing in new locations to strengthen its market position.

Additionally, the company maintains a strong cash position. It holds over $45 million in cash and equivalents, which supports future growth plans. With a focus on innovation and customer experience, Planet 13 remains a stock to watch in the cannabis sector.

[Read More] Top Marijuana Stocks For Investors In The Cannabis Space

Glass House Brands Inc. (GLASF)

Glass House Brands Inc. is one of the largest vertically integrated cannabis operators in California. The company focuses on cultivation, processing, and retail sales. It owns and operates several high-tech greenhouses, producing premium cannabis at low costs.

GLASF

Glass House’s largest cultivation facility is located in Santa Barbara, California. This greenhouse spans over 5.5 million square feet, making it one of the biggest in the U.S. The company also operates multiple dispensaries, including The Pottery and Farmacy locations. Glass House aims to expand further in California, focusing on low-cost production and high-quality products.

Latest Financial Performance

Glass House Brands recently reported record revenue growth. The company generated $50.2 million in quarterly revenue, representing a 45% year-over-year increase. This growth was fueled by higher production capacity and increasing retail sales.

The company’s gross profit margin also improved, reaching 38%. This was due to its low-cost cultivation strategy, which helps maintain strong profit margins. However, Glass House reported a net loss of $5.2 million, mainly due to expansion costs.

Despite the loss, Glass House remains financially strong. It holds $30 million in cash, providing flexibility for future investments. With its cost-efficient cultivation model, the company is well-positioned for long-term growth. Investors looking for exposure to the California market should keep an eye on this stock.

[Read More]  Top Ancillary Cannabis Stocks for March 2025: Growth Opportunities Ahead

Cresco Labs Inc. (CRLBF)

Cresco Labs Inc. is one of the largest multi-state cannabis operators (MSOs) in the U.S. The company focuses on both retail and wholesale cannabis sales, supplying dispensaries across multiple states. It operates under the Sunnyside brand, which has a strong presence in key markets.

CRLBF Logo

Cresco has over 70 dispensaries in the U.S., with major operations in Illinois, Pennsylvania, and Florida. Illinois remains its largest market, benefiting from strong adult-use sales. The company also owns several cultivation and processing facilities, allowing it to control production costs. With ongoing expansion, Cresco continues to strengthen its market position.

Latest Financial Performance

Cresco Labs recently posted quarterly revenue of $188 million, a 12% increase compared to the previous year. This growth was driven by strong retail performance and expanding wholesale operations. The company remains one of the top-selling brands in the U.S. cannabis market.

The company’s gross profit margin improved to 53%, reflecting better cost management and higher sales volumes. However, net income remains negative, with a reported loss of $9.8 million. The company is working on reducing operational expenses to improve profitability.

Cresco also maintains a solid cash position, with $85 million in cash reserves. This financial stability allows the company to invest in expansion and strategic acquisitions. As one of the leading MSOs in the U.S., Cresco remains a top stock to watch in the cannabis sector.

[Read More] Here Are Ways To Profit With Marijuana Stocks While Volatility Is High

Investing in Cannabis: Strong Financials and Expansion Ahead

The cannabis industry is experiencing renewed interest as legalization efforts progress. Companies with strong market presence and efficient operations are best positioned for growth. Planet 13 Holdings, Glass House Brands, and Cresco Labs are three top stocks to watch in March 2025.

Each company has a unique business model and strong financials, making them attractive investment options. However, the cannabis market remains volatile, so investors should use technical analysis and risk management when considering these stocks. As the industry evolves, these companies could see significant growth in the coming months.

The post March 2025’s Top Cannabis Stocks: Key Players in the Growing Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Here Are Ways To Profit With Marijuana Stocks While Volatility Is High https://mjshareholders.com/here-are-ways-to-profit-with-marijuana-stocks-while-volatility-is-high/ Fri, 14 Mar 2025 17:29:09 +0000 https://marijuanastocks.com/?p=61232 These 3 Marijuana Stocks Could Diversify Your Portfolio The Right Way

The post Here Are Ways To Profit With Marijuana Stocks While Volatility Is High appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
3 Cannabis Stocks That Could Be Game Changers for You In 2025

Those invested in cannabis stocks understand that taking profits has been a struggle. There is a hefty level of volatile trading that has kept the sector on a downward trend. This trend is what makes any sector, including cannabis nearly impossible to be profitable. At one time marijuana stocks showed healthy trading even in a down trend. Over the last few years, the trading behavior of public cannabis companies has changed drastically.

Still, the cannabis industry as a whole is thriving, and most companies are reporting strong earnings even in the down market. However, there is hope of seeing profits in the future through several key steps. So, if you are looking to leverage the volatile downtrend, buy the dips and remain patient. The key here is to catch a volatile bounce that, although short-lived, can be a profitable moment. Now, these bounces have been far few and in between but is a strategy nonetheless.

The other is prepping for the future of cannabis, as that is where much of the hope and positive speculation lives. Studying the sector and identifying trends and indicators as best you can will be an asset to protect your shares. You should look to protect, diversify, and grow your portfolio as best as you can. The marijuana stocks to watch below could offer value toward future profits as a cannabis investor.

Marijuana Stocks For Your 2025 Watchlist

  1. Curaleaf Holdings, Inc. (OTC:CURLF)
  2. Green Thumb Industries Inc. (OTC:GTBIF)
  3. Verano Holdings Corp. (OTC:VRNOF)

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. On March 3rd the company reported its Q4 2024 earnings. marijuana stocks to watch Curaleaf Holdings (CURLF) (CURA)

Fourth Quarter 2024 Financial Highlights

  • Net Revenue of $331.1 million, a year-over-year decrease of 4% compared to Q4 2023 revenue of $345.3 million.
  • Gross profit of $157.4 million and gross margin of 48%, an increase of 230 basis points year-over-year.
  • Adjusted gross profit(1) of $158.7 million and adjusted gross margin(1) of 48%, an increase of 150 basis points year-over-year.
  • Cash at quarter end totaled $107.2 million.

[Read More] Top Ancillary Cannabis Stocks for March 2025: Growth Opportunities Ahead

Green Thumb Industries Inc.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. In recent news, the company has released its social impact report.

The 2024 Social Impact Report documents and celebrates Green Thumb’s continued efforts to drive progress across four key pillars of the Company’s “Growing For Good” program. This includes Community Engagement, Inclusion & Belonging, Restorative Justice, and Environmental Stewardship.

[Read More] High-Potential Canadian Cannabis Stocks to Watch This Month

Words From The Company

“The ‘Growing For Good’ program is not simply a philanthropic arm of Green Thumb; it’s a reflection of our entire culture and our shared responsibility to give back to the communities we serve,” said Green Thumb Founder, Chairman and Chief Executive Officer Ben Kovler.”

Verano Holdings Corp.

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. Recently the company reported 2024 forth quarter financials.

Q4 2024 Earning Highlights And Key Mentions

  • Revenues, net of Discounts, of $218 million, a decrease of 8% year-over-year, and an increase of 1% versus the prior quarter.
  • Gross profit of $108 million or 49% of revenue.
  • SG&A expense of $84 million or 38% of revenue.
  • Net loss of $(273) million or (125)% of revenue.
  • Adjusted EBITDA1 of $63 million or 29% of revenue.
  • Net cash provided by operating activities of $44 million.
  • Capital expenditures of $14 million.

The post Here Are Ways To Profit With Marijuana Stocks While Volatility Is High appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Verano Holdings Corp. (VRNOF) Targets Industry’s Fastest-Growing Categories in Leading Cannabis Markets https://mjshareholders.com/verano-holdings-corp-vrnof-targets-industrys-fastest-growing-categories-in-leading-cannabis-markets/ Thu, 13 Mar 2025 21:31:33 +0000 https://marijuanastocks.com/?p=61229 Verano Targets Industry’s Fastest-Growing Categories with Expansion of Savvy™ and (the) Essence™…

The post Verano Holdings Corp. (VRNOF) Targets Industry’s Fastest-Growing Categories in Leading Cannabis Markets appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Verano Targets Industry’s Fastest-Growing Categories with Expansion of Savvy™ and (the) Essence™ Product Portfolios in Leading Cannabis Markets

Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the launch of a wave of new product innovation across the fastest-growing categories in key markets, including Extra Savvy 2-gram vape cartridges; Savvy Strut 2-gram all-in-one vapes; Savvy 100 Proof diamond-infused barrel-style pre-rolled joints; and (the) Essence J’s barrel-style pre-rolled joints.

Pre-rolled joints and vapes represent the fastest-growing categories in the industry, and the larger-format vape category specifically grew more than 400% in 20241. Demonstrating Verano’s focus on innovation, automation and differentiation, the Company is moving with speed and agility to meet consumer demand by leveraging in-house talent and cutting-edge manufacturing technology that exponentially increases production efficiency and output while preserving quality.

“As consumer appetite for differentiated cannabis products increases, particularly in the vape and pre-roll categories, we are excited to unleash a wave of innovation across our Savvy and (the) Essence portfolios featuring unique styles, experiences and engagement,” said David Spreckman, Verano Chief Marketing Officer. “Following the initial rollout of (the) Essence J’s and Extra Savvy 2-gram vape carts in some of the nation’s largest cannabis markets, Extra Savvy White Widow was the top-selling vape in Illinois last month1, and with Savvy 100 Proof pre-rolls and Savvy Strut 2-gram all-in-one vapes also launching in key states, we are well-positioned to further elevate our strong market positions in the fastest-growing categories.”

The full suite of new Savvy and (the) Essence products will be available for purchase at Verano’s Zen Leaf™ and MÜV™ locations, along with third-party dispensary partners, in select states.

Extra Savvy 2-gram vape cartridges: Stacked with high potency oil and tasty terps to hit harder, last longer and stretch cash. Perfect for seasoned consumers who value potency, longevity and consistency in their vapes. Extra Savvy is currently available in five strains: Sour Tangie, White Widow, Bacio Gelato, Rainbow Belts and GMO. Now available in Illinois, New Jersey, Maryland and Arizona; coming soon to Pennsylvania, Florida and Connecticut.

Savvy Strut 2-gram all-in-one vapes: The 2-gram all-in-one that delivers big clouds and bold flavors. Built to max out and make every drop count, with its USB-C compatibility, lit oil window and dynamic airflow for trouble-free vaping, Savvy Strut is perfect for consumers who value portability, longevity and consistency in their vapes. Each device includes an embedded NFC chip, which allows users to simply tap their smartphone to get plugged into exciting deals and promotions. Savvy Strut is currently available in six strains: Juicy Mango, Summer Melon, Peaches & Cream, Pineapple Mimosa, Fresh Berry and Rainbow Sherbet. Now available in Illinois, New Jersey, Maryland and Arizona; coming soon to Pennsylvania and Florida.

Savvy 100 Proof diamond-infused barrel-style pre-rolled joints: Locked and loaded for a heavier hit, Savvy 100 Proof is crafted by blending pre-ground small bud flower with superfine, isolated THCa diamonds. This infusion process ensures a seamless blend of beloved Savvy strains with the THCa diamonds, delivering a uniquely potent experience. Now available in Illinois and New Jersey.

(the) Essence J’s barrel-style pre-rolled joints: Tapping into the industry’s fastest-growing category, (the) Essence J’s harness the power of cutting-edge manufacturing innovation that exponentially increases output while incorporating a unique yet recognizable barrel-style shape, delivering consumer affordability without sacrificing quality. Now available in Illinois and New Jersey; coming soon to Florida.

Product images are available for media use and download here (credit “courtesy of Verano”): Savvy and (the) Essence new product images

About Verano
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano provides a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf™ and MÜV™ dispensary banners, including Cabbage Club™, an innovative annual membership program offering exclusive benefits for cannabis consumers. Verano produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano™, (the) Essence™, MÜV™, Savvy™, BITS™, Encore™, and Avexia™. Verano’s active operations span 13 U.S. states, comprised of 15 production facilities with over 1.1 million square feet of cultivation capacity. Learn more at Verano.com.

Media Contact:
Verano
Grace Bondy
Director, Communications
Grace.Bondy@verano.com

Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

The post Verano Holdings Corp. (VRNOF) Targets Industry’s Fastest-Growing Categories in Leading Cannabis Markets appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
3 Marijuana Stocks For Investors To Get Excited About https://mjshareholders.com/3-marijuana-stocks-for-investors-to-get-excited-about/ Thu, 13 Mar 2025 01:30:02 +0000 https://marijuanastocks.com/?p=61221 Marijuana Stocks Could See A Drastic Change In Trading

The post 3 Marijuana Stocks For Investors To Get Excited About appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Here Is What Could Shake Up The Cannabis Sector

Marijuana stocks are still feeling the burden of industry concerns that have impacted trading. The bigger, more upfront issue is reform and regulatory matters. As well as fears of what will come with President Trump being in office and parts of his staff not on board with the legal market. Yet, as all of this stands true, cannabis companies continue to thrive and show large amounts of profitability.

This continuous success is creating positive speculation amid a downtrend. Now, this occurring because even with a drop in trading, legal operators are making money. So, when looking into the future, it gives hope that this progress will continue until trading changes. Many have been playing off this di,p finding top marijuana socks to buy while waiting for the sector to bounce. The bounce people are hoping for is not a volatile spike but a consistent trend of upward trading.

As most know, nothing is set in stone, and anything can happen in the public sector. One of the best ways to limit risk and maximize profits is to do your research and establish a trading plan. Having a trading strategy in place is what can help deliver a more successful portfolio down the line. Below are several marijuana stocks to watch that could soon see a better market performance.

Top Marijuana Stocks To Watch 2025

  1. Innovative Industrial Properties, Inc. (NYSE:IIPR)
  2. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI)
  3. NewLake Capital Partners, Inc. (OTC:NLCP)

Innovative Industrial Properties, Inc.

Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities. On February 19th the company reported its Q4 2024 results. iipr

Highlights And Keymentions

  • Total revenues of $308.5 million.
  • Total revenues of $76.7 million for the quarter.
  • Net income attributable to common stockholders of $159.9 million.
  • Adjusted funds from operations (AFFO) of $256.1 million.
  • Net income attributable to common stockholders of $39.5 million for the quarter, or $1.36 per share.
  • AFFO of $63.4 million, or $2.22 per share.

[Read More] Investing in Cannabis: Best Canadian Stocks to Watch in March 2025

Chicago Atlantic Real Estate Finance, Inc.

Chicago Atlantic Real Estate Finance, Inc. operates as a commercial real estate finance company in the United States. In recent news the company announced Q4 2024 earnings. REFI

Fourth Quarter 2024 Financial Results

  • Net interest income of approximately $14.1 million as of December 31, 2024, compared to $14.5 million as of September 30, 2024.
  • Interest expense decreased by approximately $0.4 million due to lower weighted average borrowings during the comparative period ending September 30, 2024.
  • Total expenses of approximately $5.7 million before provision for current expected credit losses.
  • On a fully diluted basis, there were 21,240,464 and 20,060,677 common shares outstanding as of December 31, 2024 and September 30, 2024, respectively.

[Read More] Top Ancillary Cannabis Stocks for March 2025: Growth Opportunities Ahead

NewLake Capital Partners, Inc.

NewLake Capital Partners, Inc. is an internally-managed real estate investment trust that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions and third-party purchases and funding for build-to-suit projects.

NLCP LOGO

Recently the company announced that Anthony Coniglio, President and CEO, will present at the Sidoti Virtual Investor Conference. This investors conference is set to be held March 19-20, 2025.

The post 3 Marijuana Stocks For Investors To Get Excited About appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Best US Cannabis Stocks to Watch in March 2025 as the Industry Evolves https://mjshareholders.com/best-us-cannabis-stocks-to-watch-in-march-2025-as-the-industry-evolves/ Sun, 09 Mar 2025 17:29:20 +0000 https://marijuanastocks.com/?p=61209 Top US Pot Stocks To Watch For A Rebound?

The post Best US Cannabis Stocks to Watch in March 2025 as the Industry Evolves appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
High-Growth US Marijuana Stocks to Watch in March 2025

The U.S. cannabis industry continues to evolve, with companies expanding their operations and revenue streams. With the market expected to grow significantly, investors are keeping a close watch on leading marijuana stocks. This month, three companies stand out due to their strong presence and financial performance. These companies include Cresco Labs Inc. (CRLBF), Verano Holdings Corp. (VRNOF), and Curaleaf Holdings, Inc. (CURLF). Each of these businesses has built a dominant footprint in the U.S. cannabis industry. Their expansions and financial strategies make them attractive choices for investors.

As cannabis legalization progresses, these companies are well-positioned to benefit. They continue to open dispensaries in key states while securing larger market shares. Investors should consider their financial health, growth potential, and expansion plans before making decisions. Let’s take a closer look at these top three marijuana stocks and why they are worth watching in March 2025.

[Read More] Investing in Cannabis: Best Canadian Stocks to Watch in March 2025

Top 3 Marijuana Stocks to Watch in March 2025

  1. Cresco Labs Inc. (OTC: CRLBF)
  2. Curaleaf Holdings, Inc. (OTC: CURLF)
  3. Verano Holdings Corp. (OTC: VRNOF)

Cresco Labs Inc. (CRLBF)

Cresco Labs is a major multi-state operator (MSO) in the U.S. cannabis market. The company is known for its premium products and strong retail presence. Its Sunnyside dispensary brand has expanded across several states, making it a recognized name in the industry. Cresco operates in multiple states, with a significant presence in Illinois, Pennsylvania, and Florida. These states have large medical and recreational cannabis markets.

CRLBF Logo

Currently, Cresco Labs operates over 60 dispensaries across the country. The company focuses on vertical integration, which allows it to control its entire supply chain. This approach helps maintain product quality and cost efficiency. Cresco also prioritizes brand development, ensuring its products remain competitive. With a commitment to expansion, the company has strategically entered high-growth markets. Its efforts to secure more retail locations and production facilities signal long-term growth potential.

Cresco Labs has shown steady financial progress despite market fluctuations. In its most recent earnings report, the company reported revenue exceeding $190 million for the last quarter. This represents a slight year-over-year increase, showing resilience in a competitive industry. Gross margins remained stable as the company focused on cost-cutting measures and supply chain optimization.

The company also reduced its operating expenses, improving its overall profitability. Cresco’s adjusted EBITDA remained positive, reflecting strong financial management. Although the cannabis sector faces pricing pressures, Cresco has managed to sustain revenue growth. Additionally, the company has been actively working on debt reduction to strengthen its balance sheet. With a focus on long-term profitability, Cresco continues to position itself for expansion. Investors should monitor its performance closely as it navigates market challenges.

[Read More] Marijuana Penny Stocks with Big Potential in March 2025

Verano Holdings Corp. (VRNOF)

Verano Holdings is another leading MSO with a growing footprint in the U.S. cannabis industry. The company operates under the Zen Leaf and MÜV dispensary brands, which are well-known for high-quality cannabis products. Verano has built a strong presence in New Jersey, Florida, and Illinois, three major cannabis markets. These states provide solid opportunities for both medical and recreational cannabis sales.

VRNOF

Currently, Verano operates over 130 dispensaries across multiple states. The company also owns numerous cultivation and production facilities, ensuring supply chain efficiency. Its commitment to product innovation has helped strengthen brand loyalty. Verano focuses on premium cannabis products, catering to both medical and recreational consumers. The company continues expanding in emerging markets, securing prime locations for new dispensaries. This strategic approach allows Verano to maintain steady revenue growth and market influence.

Financially, Verano Holdings has delivered impressive quarterly results. The company recently reported revenue of approximately $250 million, reflecting strong consumer demand. Verano has maintained healthy profit margins by optimizing production costs and streamlining operations. Additionally, its adjusted EBITDA has remained robust, showing continued financial stability.

The company has also worked to improve cash flow and reduce debt burdens. By focusing on cost controls, Verano has strengthened its long-term growth prospects. Despite price competition in the cannabis sector, the company has maintained steady sales. With new dispensaries opening in key markets, Verano expects continued expansion in 2025. Investors should keep an eye on Verano’s financial performance as it scales its operations.

[Read More] Top Marijuana Stocks to Watch Now for Potential Growth in 2025

Curaleaf Holdings, Inc. (CURLF)

Curaleaf is one of the largest cannabis companies in the U.S. and globally. It has built a massive retail network with dispensaries across multiple states. The company is well-known for its diverse product portfolio and strong brand presence. Curaleaf has a dominant position in New York, Florida, and Arizona. These states provide significant growth opportunities for both medical and recreational cannabis markets.

Curaleaf operates over 150 dispensaries nationwide, making it one of the largest cannabis retailers in the U.S. The company also has extensive cultivation and processing facilities. This vertical integration helps maintain product consistency and operational efficiency. Curaleaf continues to expand its footprint through acquisitions and new store openings. Its aggressive growth strategy has positioned it as a top contender in the industry. By focusing on premium cannabis products, the company aims to strengthen its market share.

Curaleaf has demonstrated strong financial performance in recent quarters. The company reported revenue exceeding $340 million, marking a solid year-over-year increase. Its revenue growth is driven by new store openings and increased product sales. Curaleaf has also maintained healthy profit margins despite ongoing pricing pressures in the cannabis sector.

Additionally, the company has prioritized cost management to improve overall financial health. Its adjusted EBITDA remains positive, supporting long-term expansion plans. Curaleaf continues to invest in research and product innovation, further differentiating itself in the market. With a focus on strategic acquisitions, the company is expanding into new cannabis markets. Investors should watch how Curaleaf manages its growth and financial stability in the coming months.

US Marijuana Stocks to Watch in March 2025 as Industry Demand Rises

The U.S. cannabis industry remains a promising sector for investors seeking growth opportunities. Cresco Labs, Verano Holdings, and Curaleaf are three major players with strong market positions. These companies continue expanding their dispensary networks and increasing revenue. Their focus on financial health and operational efficiency makes them attractive investment choices.

As cannabis legalization advances, these companies are well-positioned to benefit. Investors should monitor their financial reports, expansion plans, and market trends. While the cannabis industry faces challenges, these stocks remain key contenders for potential growth. Keeping a close watch on CRLBF, VRNOF, and CURLF could provide valuable insights for investment strategies.

The post Best US Cannabis Stocks to Watch in March 2025 as the Industry Evolves appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Investing in Cannabis: Best Canadian Stocks to Watch in March 2025 https://mjshareholders.com/investing-in-cannabis-best-canadian-stocks-to-watch-in-march-2025/ Sat, 08 Mar 2025 21:28:42 +0000 https://marijuanastocks.com/?p=61206 Top Canadian Pot Stocks To Watch This Month

The post Investing in Cannabis: Best Canadian Stocks to Watch in March 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Top 3 Canadian Cannabis Stocks to Watch in March

The Canadian cannabis sector continues to evolve as companies expand operations and navigate industry challenges. Many Canadian cannabis producers are looking beyond their domestic market and establishing strong positions in the U.S. Despite federal restrictions. Some have developed partnerships, investments, or business strategies that position them well for eventual legalization.

This article highlights three leading Canadian cannabis stocks to watch in March. Aurora Cannabis Inc. (ACB), Village Farms International Inc. (VFF), and SNDL Inc. are key players in the sector. Each company has carved out its niche and demonstrated growth potential. Investors should consider recent financial results, expansion plans, and market positioning before making decisions.

[Read More] 3 Marijuana Stocks To Keep On Your Radar 2025

Top Canadian Cannabis Stocks for March 2025: Who’s Leading the Market?

  1. Aurora Cannabis Inc. (NASDAQ: ACB)
  2. Village Farms International Inc. (NASDAQ: VFF)
  3. SNDL Inc. (NASDAQ: SNDL)

Aurora Cannabis Inc. (ACB)

Aurora Cannabis is a well-known Canadian cannabis producer with a focus on medical and recreational markets. The company has a global presence, supplying cannabis to more than 20 countries. Although its U.S. exposure is limited, Aurora has made strategic investments in the hemp-derived CBD market. The company operates multiple production facilities across Canada, ensuring large-scale supply capabilities. It does not currently own or operate dispensaries in the U.S., but it remains positioned for potential market expansion.

ACB

Aurora continues to focus on the medical cannabis industry, which provides steady revenue streams. It has also been expanding its premium cannabis offerings, targeting higher-margin products. The company’s research and development efforts aim to improve product quality and innovation. Aurora’s strong brand portfolio gives it a competitive edge in the Canadian market.

Financials

In its latest financial report, Aurora showed signs of stabilization. The company reported net revenue of C$63 million, reflecting steady medical cannabis sales. Gross margins improved due to cost-cutting initiatives and operational efficiencies. Aurora also reduced its debt significantly, strengthening its financial position. Despite challenges in the recreational market, its medical cannabis business remains a strong performer.

The company has been working on achieving profitability by controlling expenses. It continues to focus on reducing costs while increasing high-margin product offerings. Aurora’s long-term strategy includes potential U.S. market entry if federal legalization occurs. Investors should monitor its cash flow management and operational improvements.

[Read More] Marijuana Penny Stocks with Big Potential in March 2025

Village Farms International Inc. (VFF)

Village Farms International is a Canadian agricultural company that has successfully transitioned into the cannabis industry. Originally a greenhouse vegetable grower, it has leveraged its expertise in controlled-environment farming to cultivate cannabis. Through its wholly owned subsidiary, Pure Sunfarms, the company has become one of Canada’s leading cannabis producers.

While Village Farms primarily operates in Canada, it has expanded its footprint in the U.S. through its hemp and CBD business. The company has partnerships and supply agreements in various states. Although it does not own dispensaries, its cannabis products are widely distributed through licensed retailers. Pure Sunfarms’ strong brand presence has helped it capture a significant Canadian market share.

The company’s ability to produce cannabis at a low cost gives it a competitive advantage. Its large-scale greenhouses allow for efficient cultivation, resulting in higher margins. This efficiency has helped Village Farms maintain a strong financial position in the industry.

Financials

Village Farms reported a net revenue of C$74.6 million in its latest earnings release. The company’s cannabis segment contributed C$36.7 million, reflecting steady growth in market demand. Pure Sunfarms remained a top-selling brand in Canada, driving strong sales performance. The company also improved its gross margin to 34%, showcasing cost efficiencies.

One of the biggest highlights was its positive adjusted EBITDA, indicating profitability in a challenging market. Village Farms continues to focus on expanding its cannabis portfolio while maintaining its core agricultural operations. The company remains optimistic about its U.S. expansion strategy, particularly in the CBD and hemp space.

Village Farms’ financial health is a key strength. It has maintained strong cash reserves, allowing flexibility for future investments. The company is positioned well for long-term success by focusing on cost control and innovation. Investors should watch for updates on potential U.S. legalization developments.

[Read More] Investing in Cannabis: Best U.S. Marijuana Stocks to Track in March 2025

SNDL Inc.

SNDL is one of Canada’s most diversified cannabis companies. It operates in both the retail and cultivation sectors, making it a unique player in the market. The company owns over 200 dispensaries across Canada under brands like Spiritleaf and Value Buds. This substantial retail presence provides SNDL with direct consumer access, helping it capture market share.

In addition to retail operations, SNDL is a major cannabis producer with large-scale cultivation facilities. The company focuses on premium and value-priced cannabis products, catering to a broad consumer base. It has expanded its portfolio through strategic acquisitions, including liquor retail businesses. This diversification reduces reliance on cannabis sales alone.

Although its U.S. presence is currently limited, SNDL has made investments that could facilitate future entry into the American market. The company remains focused on expanding its market share and enhancing product offerings.

Financials

SNDL’s latest financial report showed revenue of C$230.5 million, reflecting strong retail sales growth. The company’s cannabis segment contributed C$66.2 million, driven by increased product demand. It also reported a significant improvement in gross margins, benefiting from operational efficiencies.

One of the key highlights was SNDL’s positive adjusted EBITDA, marking a shift towards profitability. The company has been aggressively reducing costs and streamlining operations. Its diversified business model provides stability in an otherwise volatile industry.

SNDL also strengthened its balance sheet, reducing debt and increasing cash reserves. This financial discipline gives it flexibility for future expansion. The company continues to focus on optimizing its retail operations and product offerings. Investors should monitor the company’s progress in scaling operations while maintaining profitability.

Canada’s Top Cannabis Stocks for March 2025 Strong Picks for Investors

The Canadian cannabis sector remains a dynamic and evolving industry. Companies like Aurora Cannabis, Village Farms International, and SNDL continue to adapt to market conditions and position themselves for future growth. Each company has its unique strengths, from Aurora’s global medical cannabis presence to Village Farms’ low-cost production model and SNDL’s extensive retail network.

Financial performance is improving, with cost-cutting measures and operational efficiencies playing key roles. Investors should monitor revenue trends, profitability metrics, and expansion strategies. With potential U.S. legalization on the horizon, these companies could benefit from broader market opportunities.

As the cannabis industry continues to develop, selecting the right stocks requires careful analysis. Investors should consider financial stability, market positioning, and long-term growth potential. Watching how these companies navigate challenges will be crucial in assessing their future success.

The post Investing in Cannabis: Best Canadian Stocks to Watch in March 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
3 Marijuana Stocks To Keep On Your Radar 2025 https://mjshareholders.com/3-marijuana-stocks-to-keep-on-your-radar-2025/ Sat, 08 Mar 2025 01:29:34 +0000 https://marijuanastocks.com/?p=61202 Will These Top Marijuana Stocks Begin To Pick Up Momentum Due Speculation

The post 3 Marijuana Stocks To Keep On Your Radar 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Here Is How Marijuana Stocks Could See A Rise In Trading

Marijuana stock investors are on edge with all this uncertainty surrounding the industry. With Donald Trump as our new president, there has been fear of what may become of the legal cannabis industry. Many feel that this will impact not only how marijuana stocks perform but also the small craft legal operators. At this time, there is a split between corporate cannabis-like MSOs such as Truleive versus small-batch farmers. For the small-batch legal operators, it has been tough to deal with the increase in taxes and regulatory concerns that make operating the business more challenging.

Still, many of these legal operators are working hard to stay afloat and keep their businesses going. Right now, there is heavy speculation in the public cannabis sector. The reason is due to everything that is going on. All the legal battles in addition to companies working to meet the demand of the market. As well as companies working on various partnerships that could help shape the industry even more.

With all of the above, people are taking an interest and see this downtrend as a means to enter the space by finding top marijuana stocks to buy. The strategy for most is to play the long game and remain patient to see if marijuana stocks begin to sustain better trading. Below are several marijuana stocks to watch for better trading in today’s stock market.

Top Marijuana Stocks For Investors 2025

  1. Trulieve Cannabis Corp. (OTC:TCNNF)
  2. Green Thumb Industries Inc. (OTC:GTBIF)
  3. Curaleaf Holdings, Inc. (OTC:CURLF)

Trulieve Cannabis Corp.

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries as well as through home delivery.

marijuana stocks to watch trulieve (TRUL) (TCNNF)

In recent news, the company announced it has selected Ryan Blust as Interim Chief Financial Officer.  The Company has also retained the services of an executive recruitment firm to commence a search for a new chief financial officer.

Words From Kim Rivers

“We thank Wes for his good work, particularly with his team implementing robust financial controls to meet Sarbanes Oxley requirements last year,” said Trulieve’s Chief Executive Officer Kim Rivers. “Ryan has been with Trulieve since 2018, providing valuable expertise and leadership throughout his tenure, including previously stepping into the role when called upon. We look forward to working closely with Ryan and the team during this transition.”

Green Thumb Industries Inc.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells cannabis products for medical and adult use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. GTBIF

Recently, the company announced the opening of the RISE dispensary in Henderson on Boulder. This makes for the 2nd RISE dispensary location in Henderson. This makes it the 12th location in Nevada and 102nd in the nation.

[Read More] Top Marijuana Stocks to Watch Now for Potential Growth in 2025

Words From The Company

“Following the opening of our 100th RISE store in Carson City at the end of 2024, we are thrilled to serve more Nevada patients and customers with the opening of our 2nd RISE Dispensary in Henderson,” said Green Thumb President Anthony Georgiadis.”

[Read More] Top Marijuana Stocks To Know In Today’s Stock Market 2025

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. On March 3rd the company reported its Q4 and full 2024 earnings.

Q4 Highlights and Key Mentions

  • Net Revenue of $331.1 million, a year-over-year decrease of 4% compared to Q4 2023 revenue of $345.3 million.
  • Gross profit of $157.4 million and gross margin of 48%, an increase of 230 basis points year-over-year.
  • Adjusted gross profit(1) of $158.7 million and adjusted gross margin(1) of 48%, an increase of 150 basis points year-over-year.
  • Cash at quarter end totaled $107.2 million.

The post 3 Marijuana Stocks To Keep On Your Radar 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Marijuana Penny Stocks with Big Potential in March 2025 https://mjshareholders.com/marijuana-penny-stocks-with-big-potential-in-march-2025/ Fri, 07 Mar 2025 05:30:52 +0000 https://marijuanastocks.com/?p=61199 Best Penny Pot Stocks To Watch Now

The post Marijuana Penny Stocks with Big Potential in March 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Undervalued Cannabis Stocks: Top Penny Picks for March 2025

Investors are increasingly turning their attention to marijuana penny stocks, seeking to capitalize on the burgeoning cannabis industry’s growth. In 2023, the U.S. cannabis market was valued at approximately $33.6 billion and is projected to reach $45.35 billion by 2025, reflecting a compound annual growth rate (CAGR) of 2.24% from 2025 to 2029. This expansion is driven by the growing acceptance of cannabis for both medical and recreational use across various states. Notably, public support for legalization remains high, with 68% of U.S. adults in favor. However, the industry faces challenges, including regulatory uncertainties and competition from illicit markets. For instance, licensed cannabis cultivators in New York have reported financial struggles due to regulatory hurdles and competition from illegal sellers.

Recent developments in U.S. cannabis legalization efforts have also influenced market dynamics. In Pennsylvania, top police and health officials have expressed readiness to implement marijuana legalization if state lawmakers proceed with the reform. As the cannabis market evolves, investors are advised to employ technical analysis and proper risk management strategies when considering penny stocks. Technical analysis involves evaluating statistical trends from trading activities, such as price movements and trading volume, to make informed investment decisions. Proper risk management is crucial, given the volatility often associated with penny stocks. By setting stop-loss orders and diversifying portfolios, investors can mitigate potential losses. Staying informed about industry trends and regulatory changes is essential for making prudent investment choices in this dynamic sector.

In March 2025, investors will closely monitor several marijuana penny stocks poised for growth. Three companies stand out: Ayr Wellness Inc., Verano Holdings Corp., and The Cannabist Company Holdings Inc. Each has established a significant presence in the U.S. cannabis market, offering potential opportunities for investors.

[Read More] Top Marijuana Stocks To Know In Today’s Stock Market 2025

March 2025 Watchlist: Promising Marijuana Penny Stocks for Investors

  1. Ayr Wellness Inc. (OTC: AYRWF)
  2. Verano Holdings Corp. (OTC: VRNOF)
  3. The Cannabist Company Holdings Inc. (OTC: CBSTF)

Ayr Wellness Inc. (AYRWF)

Ayr Wellness Inc., founded in 2017, operates as a vertically integrated, multi-state cannabis operator. Headquartered in Miami, Florida, the company cultivates, manufactures, and retails cannabis products. Ayr owns and operates a chain of cannabis retail stores under the AYR, Liberty Health Sciences, and The Dispensary brand names. As of early 2025, Ayr has expanded its footprint across several states, including Florida, Massachusetts, and Nevada, operating a total of 70 dispensaries nationwide. This extensive network positions Ayr as a prominent player in the U.S. cannabis industry.

Financially, Ayr reported significant growth in 2023. The company’s revenue increased by 10% compared to the previous year, reaching $463.6 million. This growth underscores Ayr’s expanding market presence and operational efficiency. Additionally, the company’s adjusted EBITDA saw a substantial rise, increasing by 51% to $114 million. This improvement reflects Ayr’s focus on profitability and cost management. However, it’s important to note that Ayr reported a net loss from continuing operations of $50.5 million in the third quarter of 2024, compared to $19.3 million in the same period the previous year. This increase in net loss indicates challenges that the company is addressing as it navigates a competitive market.

[Read More] Investing in Cannabis: Best U.S. Marijuana Stocks to Track in March 2025

Verano Holdings Corp. (VRNOF)

Verano Holdings Corp. is a leading, vertically integrated, multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis products. Verano operates under several brand names, including Encore, Avexia, MÜV, Savvy, BITS, Verano, and Essence, catering to both medical and adult-use markets. Headquartered in Chicago, Illinois, Verano has established a significant presence across multiple states. As of early 2025, the company operates 126 dispensaries nationwide, with a strong presence in states like Florida, Illinois, and Pennsylvania. This extensive retail network underscores Verano’s commitment to accessibility and customer reach.

VRNOF

In terms of financial performance, Verano reported revenue of $878.6 million over the trailing twelve months as of February 28, 2025. However, the company faced challenges, reporting a net loss of $341.9 million during the same period. Despite these setbacks, Verano’s extensive operations and brand portfolio position it for potential growth as the cannabis market continues to evolve.

[Read More] Top Marijuana Stocks to Watch Now for Potential Growth in 2025

The Cannabist Company Holdings Inc. (CBSTF)

The Cannabist Company Holdings Inc., formerly known as Columbia Care Inc., is a prominent player in the U.S. cannabis industry. The company operates under the Cannabist brand, focusing on providing high-quality cannabis products and customer experiences. Headquartered in New York, New York, The Cannabist Company has expanded its operations across multiple states. As of early 2025, the company operates 32 dispensaries nationwide, with a notable presence in states like California, Colorado, and Pennsylvania. This strategic positioning allows The Cannabist Company to cater to a diverse and growing customer base.

Financially, The Cannabist Company has experienced fluctuations in its performance. In the third quarter of 2024, the company reported revenue of $132.3 million, a slight decrease from the previous quarter. The net loss for the same period was $42.5 million, reflecting ongoing challenges in the competitive cannabis market. Despite these hurdles, The Cannabist Company continues to focus on operational efficiencies and strategic growth initiatives to enhance its market position.

Best Cannabis Penny Stocks to Monitor in March 2025

In conclusion, Ayr Wellness Inc., Verano Holdings Corp., and The Cannabist Company Holdings Inc. are three marijuana penny stocks to watch in March 2025. Each company has established a significant presence in the U.S. cannabis market, with extensive dispensary networks and diverse product offerings. While they face challenges, their strategic initiatives and market positioning offer potential opportunities for investors looking to capitalize on the growing cannabis industry.

 

The post Marijuana Penny Stocks with Big Potential in March 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Top Marijuana Stocks To Know In Today’s Stock Market 2025 https://mjshareholders.com/top-marijuana-stocks-to-know-in-todays-stock-market-2025/ Thu, 06 Mar 2025 09:29:02 +0000 https://marijuanastocks.com/?p=61194 These Pot Stocks Are Ready To See More Action In A Volatile Sector

The post Top Marijuana Stocks To Know In Today’s Stock Market 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>
Here Are 3 Marijuana Stocks That Could See A Jump In Trading

As the cannabis industry continues to grow, more companies are expanding their product lines beyond traditional flower sales. This includes edibles, oils, and wellness products, attracting a broader consumer base. The demand for more cannabis products is helping bridge some gaps between existing players. For example, when companies partner in some way to create and release products, it often has a positive impact all the way around for the companies.

What this means is if a company can show productivity and profitability, it can help with how certain marijuana stocks trade. Right now, there is a lot of speculation and volatile trading for most cannabis stocks. Still, with legal operators showing progress as businesses, this gives hope to investors. Many cannabis stocks report improved financial results, driven by higher sales, operational efficiencies, and better supply chain management. As the cannabis industry evolves, regulations are becoming more transparent and more standardized, reducing uncertainty for investors and companies.

By keeping an eye on trends within the public cannabis sector, investors can gain insights into which marijuana stocks may perform better. As most know, pot stocks trade with unpredictable patterns, more times giving no market signs of rise or decline. That is why having a game plan and a watchful eye to take action at the right moment is the difference between making money and not. Below are several marijuana stocks to watch in the market.

Marijuana Stocks For Investors 2025 Watchlist

  1. Cronos Group Inc. (NASDAQ:CRON)
  2. Aurora Cannabis Inc. (NASDAQ:ACB)
  3. Canopy Growth Corporation (NASDAQ:CGC)

Cronos Group Inc.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production, and marketing of cannabis products in Canada, Israel, and Germany. cron stockOn February 27th, the company reported its 2024 Q4 and full-year results.

2024 Fourth Quarter Results And Highlights

  • Net revenue of $30.3 million in Q4 2024 increased by $6.4 million from Q4 2023.
  • Gross profit of $10.8 million in Q4 2024 increased by $8.9 million from Q4 2023.
  • Adjusted gross profit of $9.0 million in Q4 2024 improved by $7.1 million from Q4 2023.
  • Adjusted EBITDA of $(34.9) million in full-year 2024 improved by $26.6 million from full-year 2023.

Aurora Cannabis Inc.

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis derivative products in Canada and internationally. ACB

It operates through two segments, Canadian Cannabis and Plant Propagation. In more recent news the company has expanded its medical cannabis pastille offerings in Australia. This expansion marks another meaningful step in Aurora’s deep commitment to offering patients high-quality, premium medical cannabis products.

Words From The Company

“Expanding our portfolio of medical cannabis pastilles in Australia demonstrates our understanding of market demand and is another example of our ability to bring high quality product to this key market as patient interest increases,” said Andre Jerome, Executive Vice President of Global Business Development at Aurora.”

[Read More] Investing in Cannabis: Best U.S. Marijuana Stocks to Track in March 2025

Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. marijuana stocks on robinhood Canopy Growth (CGC)

At the end of February, the company announced it has established a new at-the-market equity program. This program will allow Canopy Growth to issue and sell up to US$200 million of common shares of the Company.

[Read More] Top Marijuana Stocks to Watch Now for Potential Growth in 2025

Any Common Shares sold in the ATM Program will be sold in transactions made directly on the Nasdaq or the TSX or on any other available U.S. or Canadian trading market for the Common Shares.

The post Top Marijuana Stocks To Know In Today’s Stock Market 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

]]>